EMA Authorised: Zebinix (eslicarbazepine acetate) — BIAL - Portela & Ca, S.A.

View source ↗

Summary

Zebinix (eslicarbazepine acetate) has been authorised in the European Union for epilepsy by BIAL.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Zebinix (eslicarbazepine acetate)

Snippet

Status: Authorised. Therapeutic area: Epilepsy. MAH: BIAL - Portela & Ca, S.A.. Decision date: 09/07/2026